Eocene Ltd.

US$2.74As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:EOCNHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (52.64%)
Div yield —
ROE (68.21%)
Biotechnology
Beta (5Y) 0.72
PE TTM —
TSR TTM (75.00%)
Mkt cap US$2.854M
ROIC (37.27%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.21
17.15%
163.57%
Hold 9|12|8|5|6
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.03
0.04
0.04
0.04
31.04%
28.21%
19.68%
15.77%
Revenue$M
0.173
0.168
0.173
0.170
2.28%
(0.06%)
5.59%
1.88%
Peers (US$2.854M)
Cap (US$)
PE
4.606M
—
Capital
TTM
5Y
10Y
Leveragex
0.580
0.267
0.254
EBIT/Intx
2.230
0.117
0.079
Own earn%
(186.09)
98.29
109.19
Sh yield%
23.65
35.69
35.44
Owners
Insiders/Inst%
12.15
79.41
Short interest%
3.70
SBC / revenue%
1.11
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
13–24
$1 testx
0.0
Incr. ROIC%
3